ALIPAY+
10.11.2021 08:15:11 CET | Business Wire | Press release
Whale Cloud , a leading technology company providing software solutions and services for telecommunications and multiple other industries, today reached a partnership with Toka Fintech , a Mexican-leading financial group, to help it develop its own digital payment app with Alipay+ Digital Wallet Solution, providing Mexicans with better access to inclusive financial services.
Toka Fintech is a company belonging to Grupo Toka, which is one of the most important groups in the prepaid card market and has more than 4.5 million customers in Mexico. Grupo Toka is increasingly embracing digital payment services because of the fast adoption of smartphones in the country and the COVID-19 pandemic.
In this partnership, with proven payment technology, project delivery and operation experience from Whale Cloud and Ant Group in global markets, Toka Fintech will further embark on its digital payment journey and bring the inclusive, digitalized and personalized services to more businesses and customers in Mexico.
Whale Cloud and Ant Group will help Toka Fintech develop an all-in-one digital payment app tailored for Latin America market, providing comprehensive payment services powered by innovative technologies including financial-grade cloud native computing and AI-driven risk management.
“As a company that aims to continuously create value for customers, Toka Fintech is taking the lead in encouraging the use of innovative technologies in the delivery of financial services. The partnership with Ant Group and Whale Cloud is a milestone for us to advance financial inclusion,” said Hugo Villanueva, CEO and Owner of Toka Fintech.
“We’re excited to serve the digital payment journey of Toka Fintech,” said Cheng Guoming, General Manager of Alipay+ Global Partnership, Ant Group. “Together with Whale Cloud, we are willing to share our technical know-how and experiences to accelerate customers’ digital transformation and help underbanked communities across the world enjoy more inclusive services.”
“Toka Fintech will be the first in Latin America to adopt Alipay+ Digital Wallet Solution. Whale Cloud is so happy to turn Toka’s strategy into actions to reinforce its market position in advancing inclusive digital services”, said Ben Zhou, CEO International, Whale Cloud.
Alipay+ Digital Wallet Solution provides a full-suite of payment technologies and products to help customers develop their own e-wallet apps more efficiently, enable their users to top up, transfer, withdraw money and enjoy financial services directly from mobile devices, while allow merchants to accept these users' online and offline payments, and manage their own loyalty and promotion campaigns.
Whale Cloud and Ant Group have formed a strategic partnership since 2020 to provide customers across industries with financial technology consulting, solution designing and delivery, and operation services.
About Grupo Toka and Toka Fintech
Toka Internacional, S.A.P.I. de C.V. “Toka” is a Mexican Company active in the issue of payment solutions, through electronic wallets in order to provide food, fuel, restaurant, travel allowance, etc. voucher services. The company started providing call center services to financial institutions and in 2012 they launched their first pre-payment card, business that has grown rapidly and become one of the top 5 electronic wallet issuer companies in Mexico.
In 2019 Toka created “Toka Fintech” as a strategy for continuous growth and taking advantage of the opportunity created by the new Fintech law in Mexico to commercialize its products to a B2C open market.
About Whale Cloud
Whale Cloud Technology Co., Ltd ("Whale Cloud") is a leading technology company specializing in telecom software development and delivery, cloud computing, big data analytics, AI-enabled service operations, IoT, Fintech solutions and other professional services including planning and consulting. Founded in 2003, the company provides services to various market segments including telecom operators, governments, and enterprises around the world. Whale Cloud’s business scope extends from telecom markets to vertical industries. It has built its core competitiveness in communications software, operation services, cloud computing, big data analytics, AI, and Internet architecture.
About Alipay+
Alipay+ provides global cross-border mobile payments and marketing solutions that enable global e-wallets and merchant partners, especially small and medium-sized businesses, to better serve their users and customers.
Alipay+ is introduced by Ant Group, the owner and operator of Alipay. One of the world’s leading digital payment platforms, Alipay serves hundreds of millions of users by connecting them with merchants and partner financial institutions that offer inclusive financial services and digital daily life services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006725/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom